Greenleaf Trust purchased a new stake in Aemetis, Inc. (NASDAQ:AMTX – Get Rating) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 11,000 shares of the specialty chemicals company’s stock, valued at approximately $139,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in AMTX. Spire Wealth Management raised its position in shares of Aemetis by 121.5% in the fourth quarter. Spire Wealth Management now owns 4,962 shares of the specialty chemicals company’s stock valued at $61,000 after buying an additional 2,722 shares in the last quarter. Buckingham Strategic Partners bought a new position in Aemetis in the fourth quarter valued at approximately $123,000. Janney Montgomery Scott LLC bought a new position in Aemetis in the fourth quarter valued at approximately $133,000. Sprott Inc. bought a new position in Aemetis in the fourth quarter valued at approximately $134,000. Finally, Raymond James & Associates bought a new position in Aemetis in the fourth quarter valued at approximately $136,000. 52.75% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
AMTX has been the topic of a number of recent analyst reports. Ascendiant Capital Markets cut shares of Aemetis to an “outperform” rating and set a $33.00 price objective on the stock. in a research note on Monday, June 6th. Credit Suisse Group decreased their price objective on shares of Aemetis from $35.00 to $27.00 and set an “outperform” rating on the stock in a research note on Monday, June 13th. Finally, StockNews.com initiated coverage on shares of Aemetis in a research note on Thursday, March 31st. They issued a “sell” rating on the stock. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $31.00.
Aemetis Stock Up 5.4 %
NASDAQ AMTX opened at $5.30 on Friday. The firm’s fifty day moving average price is $6.64 and its two-hundred day moving average price is $9.53. Aemetis, Inc. has a fifty-two week low of $4.45 and a fifty-two week high of $23.33.
Aemetis (NASDAQ:AMTX – Get Rating) last posted its earnings results on Thursday, May 12th. The specialty chemicals company reported ($0.54) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.17). The business had revenue of $52.05 million for the quarter, compared to analysts’ expectations of $55.52 million. As a group, sell-side analysts expect that Aemetis, Inc. will post -1.78 earnings per share for the current year.
Aemetis, Inc operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.
Receive News & Ratings for Aemetis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aemetis and related companies with MarketBeat.com’s FREE daily email newsletter.